AAAAAA
Results:
1-24
|
Results: 24
Authors:
RADOMSKI KM
DAVIS GA
CHANDLER MHH
Citation: Km. Radomski et al., GENERAL VERSUS SUBPOPULATION VALUES IN BAYESIAN PREDICTION OF AMINOGLYCOSIDE PHARMACOKINETICS IN HEMATOLOGY-ONCOLOGY PATIENTS, American journal of health-system pharmacy, 54(5), 1997, pp. 541-544
Authors:
PATEL T
RADOMSKI KM
CHANDLER MHH
Citation: T. Patel et al., ASSAY INTERACTION BETWEEN OXAPROZIN AND PHENYTOIN, The Annals of pharmacotherapy, 31(2), 1997, pp. 254-254
Authors:
CHANDLER MHH
SCHULDHEISZ S
PHILLIPS BA
MUSE KN
Citation: Mhh. Chandler et al., PREMENSTRUAL ASTHMA - THE EFFECT OF ESTROGEN ON SYMPTOMS, PULMONARY-FUNCTION, AND BETA(2)-RECEPTORS, Pharmacotherapy, 17(2), 1997, pp. 224-234
Authors:
MCCOY RA
CLIFTON GD
BOOTH DC
BARTELS LA
CHANDLER MHH
Citation: Ra. Mccoy et al., T-LYMPHOCYTE BETA(2)-ADRENERGIC RECEPTOR FUNCTION AND DENSITY AFTER ACUTE MYOCARDIAL-INFARCTION, Pharmacotherapy, 17(2), 1997, pp. 357-362
Authors:
DAVIS GA
CHANDLER MHH
Citation: Ga. Davis et Mhh. Chandler, COMPARISON OF CREATININE CLEARANCE ESTIMATION METHODS IN PATIENTS WITH TRAUMA, American journal of health-system pharmacy, 53(9), 1996, pp. 1028-1032
Authors:
LEADER WG
PESTOTNIK SL
CHANDLER MHH
Citation: Wg. Leader et al., INTEGRATING PHARMACOKINETICS INTO POINT-OF-CARE INFORMATION-SYSTEMS, Clinical pharmacokinetics, 31(3), 1996, pp. 165-173
Authors:
HOPPE S
CHANDLER MHH
Citation: S. Hoppe et Mhh. Chandler, CONSTRUCTIVE VERSUS DESTRUCTIVE CRITICISM, American journal of health-system pharmacy, 52(1), 1995, pp. 103-103
Authors:
LEADER WG
CHANDLER MHH
CASTIGLIA M
Citation: Wg. Leader et al., PHARMACOKINETIC OPTIMIZATION OF VANCOMYCIN THERAPY, Clinical pharmacokinetics, 28(4), 1995, pp. 327-342
Authors:
WERMELING DP
CHANDLER MHH
SIDES GD
COLLINS D
MUSE KN
Citation: Dp. Wermeling et al., DIRITHROMYCIN INCREASES ETHINYL ESTRADIOL CLEARANCE WITHOUT ALLOWING OVULATION, Obstetrics and gynecology, 86(1), 1995, pp. 78-84
Authors:
BUTLER DR
KUHN RJ
CHANDLER MHH
Citation: Dr. Butler et al., PHARMACOKINETICS OF ANTIINFECTIVE AGENTS IN PEDIATRIC-PATIENTS, Clinical pharmacokinetics, 26(5), 1994, pp. 374-395
Authors:
WERMELING DP
FEILD CJ
SMITH DA
CHANDLER MHH
CLIFTON GD
BOYLE DA
Citation: Dp. Wermeling et al., EFFECTS OF LONG-TERM ORAL CARVEDILOL ON THE STEADY-STATE PHARMACOKINETICS OF ORAL DIGOXIN IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Pharmacotherapy, 14(5), 1994, pp. 600-606
Authors:
TSUBAKI T
CHANDLER MHH
Citation: T. Tsubaki et Mhh. Chandler, EVALUATING NEW AND TRADITIONAL METHODS FOR AMINOGLYCOSIDE DOSING IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION, Pharmacotherapy, 14(3), 1994, pp. 330-336
Authors:
LEADER WG
WOLF KM
COOPER TM
CHANDLER MHH
Citation: Wg. Leader et al., SYMPTOMATOLOGY, PULMONARY-FUNCTION AND RESPONSE, AND T-LYMPHOCYTE BETA(2)-RECEPTORS DURING SMOKING CESSATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, Pharmacotherapy, 14(2), 1994, pp. 162-172
Authors:
CAI WM
HATTON J
PETTIGREW LC
DEMPSEY RJ
CHANDLER MHH
Citation: Wm. Cai et al., A SIMPLIFIED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR DIRECT DETERMINATION OF WARFARIN ENANTIOMERS AND THEIR PROTEIN-BINDING IN STROKE PATIENTS, Therapeutic drug monitoring, 16(5), 1994, pp. 509-512
Authors:
BLOUIN RA
MCNAMARA PJ
CHANDLER MHH
KOSTENBAUDER HB
Citation: Ra. Blouin et al., DEVELOPMENT OF A CLINICAL-PHARMACOLOGY GRADUATE PROGRAM AT THE UNIVERSITY-OF-KENTUCKY, American journal of pharmaceutical education, 58(3), 1994, pp. 289-293
Authors:
CAI WM
TAN HS
LING SS
CHANDLER MHH
Citation: Wm. Cai et al., CLINICAL PHARMACY PRACTICE IN URBAN CHINA, American journal of hospital pharmacy, 51(5), 1994, pp. 695-696
Authors:
TSUBAKI T
IGA T
CHANDLER MHH
Citation: T. Tsubaki et al., HEALTH-CARE AND INSTITUTIONAL PHARMACY PRACTICE IN JAPAN, American journal of hospital pharmacy, 51(4), 1994, pp. 535-538
Authors:
LEADER WG
TSUBAKI T
CHANDLER MHH
Citation: Wg. Leader et al., CREATININE-CLEARANCE ESTIMATES FOR PREDICTING GENTAMICIN PHARMACOKINETIC VALUES IN OBESE PATIENTS, American journal of hospital pharmacy, 51(17), 1994, pp. 2125-2130
Authors:
FLEMING WK
HERRINGTON AM
CHANDLER MHH
Citation: Wk. Fleming et al., PREVENTING THEOPHYLLINE DOSING ERRORS FROM CONVERSION OF DYPHYLLINE, The Annals of pharmacotherapy, 27(6), 1993, pp. 792-793
Authors:
BUFFINGTON DE
LAMPASONA V
CHANDLER MHH
Citation: De. Buffington et al., COMPUTERS IN PHARMACOKINETICS - CHOOSING SOFTWARE FOR CLINICAL DECISION-MAKING, Clinical pharmacokinetics, 25(3), 1993, pp. 205-216
Authors:
TSUBAKI T
GOODIN S
LEADER WG
CHANDLER MHH
Citation: T. Tsubaki et al., ESTIMATION OF CREATININE CLEARANCE IN PATIENTS WITH GYNECOLOGIC CANCER, Clinical pharmacy, 12(9), 1993, pp. 685-690
Authors:
WELCH LP
LEADER WG
CHANDLER MHH
Citation: Lp. Welch et al., PREDICTING VANCOMYCIN PHARMACOKINETICS BY USING AMINOGLYCOSIDE PHARMACOKINETICS, Clinical pharmacy, 12(12), 1993, pp. 909-913
Authors:
RHONEY DH
LEADER WG
CHANDLER MHH
Citation: Dh. Rhoney et al., MODIFIED MICHAELIS-MENTEN EQUATION FOR ESTIMATING UNBOUND-PHENYTOIN CONCENTRATIONS, Clinical pharmacy, 12(12), 1993, pp. 913-917
Authors:
CAI WM
LEADER WG
PORTER WH
CHANDLER MHH
Citation: Wm. Cai et al., INFLUENCE OF SERUM SEPARATOR TUBES ON TOTAL AND FREE PHENYTOIN CONCENTRATIONS AND DOSAGES, Therapeutic drug monitoring, 15(5), 1993, pp. 427-430
Risultati:
1-24
|